Acetazolamide 250mg tablets

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

지금 구매하세요

Download 환자 정보 전단 (PIL)
01-06-2019
Download 제품 특성 요약 (SPC)
14-08-2019
Download 공공 평가 보고서 (PAR)
20-04-2020

유효 성분:

Acetazolamide

제공처:

Advanz Pharma

ATC 코드:

S01EC01

INN (국제 이름):

Acetazolamide

복용량:

250mg

약제 형태:

Oral tablet

관리 경로:

Oral

수업:

No Controlled Drug Status

처방전 유형:

Valid as a prescribable product

제품 요약:

BNF: 11060000; GTIN: 5060010283911

환자 정보 전단

                                READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION
FOR YOU.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their symptoms
are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this
leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Acetazolamide 250mg Tablets are and what they are used for
2. What you need to know before you take Acetazolamide 250mg Tablets
3. How to take Acetazolamide 250mg Tablets
4. Possible side effects
5. How to store Acetazolamide 250mg Tablets
6. Contents of the pack and other information
1. WHAT ACETAZOLAMIDE 250MG TABLETS ARE AND WHAT THEY ARE USED FOR
Acetazolamide 250mg Tablets (referred to as Acetazolamide 250mg
Tablets throughout this leaflet) contain the active
substance Acetazolamide. This belongs to a group of medicines known as
carbonic anhydrase inhibitors.
Acetazolamide 250mg Tablets are used to treat:
• glaucoma (a condition of the eye), by reducing the pressure within
the eye.
• abnormal retention of fluids (Acetazolamide 250mg Tablets acts as
a diuretic)
• epilepsy (fits or convulsions).
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ACETAZOLAMIDE 250MG TABLETS
DO NOT TAKE ACETAZOLAMIDE 250MG TABLETS IF:
• you know you are allergic to sulphonamides, sulphonamide
derivatives including acetazolamide or to any of the
ingredients in the medicine (listed in Section 6)
• you have severe liver problems
• you have or have ever had severe kidney problems
• you have a particular type of glaucoma known as chronic non
congestive angle closure glaucoma (your doctor will
be able to advise you)
• you have reduced function of the adrenal glands – glands above
the kidneys – (also known as Addison’s disease)
• you have low blood levels of sodium and/or
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                OBJECT 1
ACETAZOLAMIDE 250MG TABLETS
Summary of Product Characteristics Updated 23-Aug-2019 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
DIAMOX* 250mg Tablets
Acetazolamide Mercury Pharma 250mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 250mg acetazolamide BP.
Excipient(s) with known effect
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet.
White, circular shallow biconvex tablets with quarter breakline on one
side and engraved “FW” and
“147” on other side.
4. Clinical particulars
4.1 Therapeutic indications
DIAMOX Tablets are for oral administration.
Acteazolamide is an enzyme inhibitor which acts specifically on
carbonic anhydrase. It is indicated in the
treatment of:
i) _Glaucoma:_ DIAMOX Tablets is useful in glaucoma (chronic simple
(open angle) glaucoma, secondary
glaucoma, and perioperatively in acute angle closure glaucoma where
delay of surgery is desired in order
to lower intr
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림